BRIEF published on 12/03/2024 at 13:52, 1 year ago Warimpex Faces Strategic Shift Amid Asset Sales Financial Performance Real Estate Development Market Strategy Asset Sale Warimpex
PRESS RELEASE published on 12/03/2024 at 13:47, 1 year ago Original-Research: Warimpex Finanz- und Beteiligungs-AG (von East Value Research GmbH ): BUY East Value Research GmbH updates recommendation to BUY Warimpex Finanz- und Beteiligungs-AG shares following sale of Russian assets. Focus on office projects in Poland and Germany Buy Recommendation East Value Research Warimpex Russian Assets Sale Office Projects
BRIEF published on 09/20/2024 at 06:31, 1 year 2 months ago Warimpex fait face à des défis malgré la croissance de son chiffre d'affaires au deuxième trimestre 2024 Warimpex Projets De Développement Résultats Du T2/24 Immeubles D'investissement Exposition Russe
BRIEF published on 09/20/2024 at 06:31, 1 year 2 months ago Warimpex Faces Challenges Despite Revenue Growth in Q2/24 Investment Properties Development Projects Warimpex Q2/24 Results Russian Exposure
PRESS RELEASE published on 09/20/2024 at 06:26, 1 year 2 months ago Original-Research: www.warimpex.com (von East Value Research GmbH ): East Value Research GmbH classification update on www.warimpex.com, target price at EUR 1.60. Analysis of Q2/24 results, impact of Russian properties, revenue increase, profit estimates. Focus on exposure to Russia Target Price Revenue Analysis East Value Research Warimpex Russian Properties
BRIEF published on 06/06/2024 at 06:46, 1 year 5 months ago Warimpex fait face à des défis dans un contexte de taux d'occupation élevés des hôtels Durabilité Hôtellerie Russie Résultats Du Premier Trimestre Warimpex
BRIEF published on 06/06/2024 at 06:46, 1 year 5 months ago Warimpex Faces Challenges Amid Strong Hotel Occupancy Rates Sustainability Q1 Results Russia Warimpex Hotel Business
PRESS RELEASE published on 06/06/2024 at 06:41, 1 year 5 months ago Original-Research: Warimpex Finanz- und Beteiligungs AG (von East Value Research GmbH ): East Value Research GmbH releases an update on Warimpex Finanz- und Beteiligungs AG, highlighting weak Q1/24 results driven by factors like the weak rouble FX rate and issues with Russian tenants Investment Properties Warimpex Finanz- Und Beteiligungs AG East Value Research GmbH Q1/24 Results Russian Market
BRIEF published on 05/08/2024 at 16:37, 1 year 6 months ago Warimpex Financial Report and New Target Price by East Value Research Financial Analysis Real Estate Sector Warimpex Finanz- Und Beteiligungs AG East Value Research Russian Market Exposure
BRIEF published on 05/08/2024 at 16:37, 1 year 6 months ago Rapport financier Warimpex et nouveau prix cible par East Value Research Analyse Financière Secteur Immobilier Warimpex Finanz- Und Beteiligungs AG Recherche Sur La Valeur Est Exposition Au Marché Russe
Published on 12/05/2025 at 02:35, 5 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 8 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 38 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 18 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 43 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 54 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 54 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 9 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 24 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
